Reporter brief
The Safety and Effectivness of Quercetin and Dasatinib on the Epigenetic Aging Rates in Healthy Individuals
What happened
Trial registry update: UNKNOWN. No results reported in the supplied registry record.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- Observational design cannot establish that quercetin and dasatinib caused any changes in epigenetic aging, only whether they co-occurred
- No sample size, effect sizes, or statistical significance reported, so the magnitude and reliability of any findings are unknown
- No control group mentioned, so changes cannot be distinguished from natural variation or placebo effects
Study design and sample
Observational; Human.
Healthy individuals
- Design
- Observational
- Sample
- —
- Journal
- TruDiagnostic
- Published
- Aug 3, 2021
Effect size
Not recorded.
Caveats
- Assessment: Unassessed.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Senolytics timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.